Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
- Antoniou, A.C.
- Beesley, J.
- McGuffog, L.
- Sinilnikova, O.M.
- Healey, S.
- Neuhausen, S.L.
- Ding, Y.C.
- Rebbeck, T.R.
- Weitzel, J.N.
- Lynch, H.T.
- Isaacs, C.
- Ganz, P.A.
- Tomlinson, G.
- Olopade, O.I.
- Couch, F.J.
- Wang, X.S.
- Lindor, N.M.
- Pankratz, V.S.
- Radice, P.
- Manoukian, S.
- Peissel, B.
- Zaffaroni, D.
- Barile, M.
- Viel, A.
- Allavena, A.
- Dall'Olio, V.
- Peterlongo, P.
- Szabo, C.I.
- Zikan, M.
- Claes, K.
- Poppe, B.
- Foretova, L.
- Mai, P.L.
- Greene, M.H.
- Rennert, G.
- Lejbkowicz, F.
- Glendon, G.
- Ozcelik, H.
- Andrulis, I.L.
- Thomassen, M.
- Gerdes, A.M.
- Sunde, L.
- Cruger, D.
- Jensen, U.B.
- Caligo, M.
- Friedman, E.
- Kaufman, B.
- Laitman, Y.
- Milgrom, R.
- Dubrovsky, M.
- Cohen, S.
- Borg, A.
- Jernstrom, H.
- Lindblom, A.
- Rantala, J.
- Stenmark-Askmalm, M.
- Melin, B.
- Nathanson, K.
- Domchek, S.
- Jakubowska, A.
- Lubinski, J.
- Huzarski, T.
- Osorio, A.
- Lasa, A.
- Duran, M.
- Tejada, M.I.
- Godino, J.
- Benitez, J.
- Hamann, U.
- Kriege, M.
- Hoogerbrugge, N.
- Luijt, R.B. van der
- Asperen, C.J. van
- Devilee, P.
- Meijers-Heijboer, E.J.
- Blok, M.J.
- Aalfs, C.M.
- Hogervorst, F.
- Rookus, M.
- Cook, M.
- Oliver, C.
- Frost, D.
- Conroy, D.
- Evans, D.G.
- Lalloo, F.
- Pichert, G.
- Davidson, R.
- Cole, T.
- Cook, J.
- Paterson, J.
- Hodgson, S.
- Morrison, P.J.
- Porteous, M.E.
- Walker, L.
- Kennedy, M.J.
- Dorkins, H.
- Peock, S.
- Godwin, A.K.
- Stoppa-Lyonnet, D.
- Pauw, A. de
- Mazoyer, S.
- Bonadona, V.
- Lasset, C.
- Dreyfus, H.
- Leroux, D.
- Hardouin, A.
- Berthet, P.
- Faivre, L.
- Loustalot, C.
- Noguchi, T.
- Sobol, H.
- Rouleau, E.
- Nogues, C.
- Frenay, M.
- Venat-Bouvet, L.
- Hopper, J.L.
- Daly, M.B.
- Terry, M.B.
- John, E.M.
- Buys, S.S.
- Yassin, Y.
- Miron, A.
- Goldgar, D.
- Singer, C.F.
- Dressler, A.C.
- Gschwantler-Kaulich, D.
- Pfeiler, G.
- Hansen, T.V.O.
- Jnson, L.
- Agnarsson, B.A.
- Kirchhoff, T.
- Offit, K.
- Devlin, V.
- Dutra-Clarke, A.
- Piedmonte, M.
- Rodriguez, G.C.
- Wakeley, K.
- Boggess, J.F.
- Basil, J.
- Schwartz, P.E.
- Blank, S.V.
- Toland, A.E.
- Montagna, M.
- Casella, C.
- Imyanitov, E.
- Tihomirova, L.
- Blanco, I.
- Lazaro, C.
- Ramus, S.J.
- Sucheston, L.
- Karlan, B.Y.
- Gross, J.
- Schmutzler, R.
- Wappenschmidt, B.
- Engel, C.
- Meindl, A.
- Lochmann, M.
- Arnold, N.
- Heidemann, S.
- Varon-Mateeva, R.
- Niederacher, D.
- Sutter, C.
- Deissler, H.
- Gadzicki, D.
- Preisler-Adams, S.
- Kast, K.
- Schonbuchner, I.
- Caldes, T.
- Hoya, M. de la
- Aittomaki, K.
- Nevanlinna, H.
- Simard, J.
- Spurdle, A.B.
- Holland, H.
- Chen, X.Q.
- Platte, R.
- Chenevix-Trench, G.
- Easton, D.F.
- Ontario Canc Genetics Network
- SWE-BRCA
- HEBON
- EMBRACE
- GEMO
- Breast Canc Family Registry
- kConFab
- CIMBA
DOIAbstract
The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional carriers in a sample of 12,525 BRCA1 and 7,409 BRCA2 carriers. Additionally, we investigated potential interactions between SNPs and assessed the implications for risk prediction. The minor alleles of rs4973768 and rs10941679 were associated with increased breast cancer risk for BRCA2 carriers (per-allele HR - 1.10, 95% CI: 1.03-1.18, P - 0.006 and H...
Add to ORKG